This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Tokyo Medical and Dental University. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Innovations by Tatsuyuki Kawano in Cancer Therapy
Introduction
Tatsuyuki Kawano, an innovative inventor based in Tokyo, Japan, has made significant contributions to the field of cancer research. With two notable patents to his name, Kawano focuses on utilizing microRNAs for cancer diagnosis and therapy, demonstrating his commitment to advancing medical science.
Latest Patents
Kawano's latest patents include a groundbreaking method for assaying microRNA, a cancer therapeutic agent, and a medical composition that contains the aforementioned components for cancer therapy. His research has discovered microRNAs strongly linked to the stabilization of NRF2 in tumors. The objective of his inventions is to harness these microRNAs for cancer diagnosis and treatment. Through extensive screening of 470 microRNAs in a library using HeLa cells, he identified eight microRNAs that showed a significant decrease in activity compared to a control and eight others that exhibited increased activity. These findings have implications for detecting NRF2 activation in tumor cells, allowing for differentiation of tumor malignancies. Furthermore, Kawano's research indicates that nucleic acids containing miRNA sequences associated with reduced ARE activity can serve as effective cancer therapeutic agents.
Career Highlights
Kawano is affiliated with the National University Corporation Tokyo Medical and Dental University, where his work emphasizes the integration of molecular biology in cancer treatment. His innovative approach has positioned him as a key figure in the intersection of research and practical applications in cancer therapy.
Collaborations
Collaboration is vital in scientific advancements, and Kawano has worked alongside esteemed colleagues such as Johji Inazawa and Jun Inoue. Together, they contribute to the enhanced understanding and treatment of cancer, focusing on the potential uses of microRNAs in medical science.
Conclusion
Tatsuyuki Kawano exemplifies the spirit of innovation in the medical field, particularly in cancer research. His patents not only showcase his inventive capabilities but also promise significant advancements in cancer diagnosis and treatment through the application of microRNA technology. As research continues to evolve, Kawano's work will undoubtedly play a pivotal role in shaping future therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile